suptavumab development code humanized monoclonal antibody designed prevention medically attended lower respiratory tract disease due respiratory syncytial virus experimental drug candidate developed regeneron pharmaceuticals inc discontinued unsuccessful phase iii clinical monoclonal article stub help wikipedia expanding httpsenwikipediaorgwikisuptavumab